To Assess the Safety, Tolerability and Pharmacokinetics of AZD5634 Following Inhaled and Intravenous (IV)Dose Administration
Clinical trial NCT02679729 · COMPLETED
Trial details
- NCT number
- NCT02679729
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-11
- Primary completion
- 2016-10-24
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.